Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770623039839 Cache Key: cqdTagPageBySlug:cancer-immunotherapy fetchCache[cqdTagPageBySlug:cancer-immunotherapy].expirationTime: falsey fetchCache[cqdTagPageBySlug:cancer-immunotherapy]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: -115382 -- Key: cqdTagPageBySlug:dementia, seconds remaining: -138580 -- Key: cqdTagPageBySlug:invasive-mechanical-ventilation, seconds remaining: -138440 -- Key: cqdPostsByTag:cqd-migrated-tag-1871,1,10, seconds remaining: -138509 -- Key: cqdPostsByTag:cqd-migrated-tag-21177,1,10, seconds remaining: -138369 -- Key: cqdTagPageBySlug:nursing-strategy, seconds remaining: -136595 -- Key: cqdPostsByTag:cqd-migrated-tag-19519,1,10, seconds remaining: -136520 -- Key: cqdTagPageBySlug:neurogenetics, seconds remaining: -128491 -- Key: cqdPostsByTag:cqd-migrated-tag-19303,1,10, seconds remaining: -128416 -- Key: cqdTagPageBySlug:stroke-care-delivery, seconds remaining: -122591 -- Key: cqdPostsByTag:cqd-migrated-tag-22654,1,10, seconds remaining: -122515 -- Key: cqdTagPageBySlug:aua17, seconds remaining: -118741 -- Key: cqdPostsByTag:cqd-migrated-tag-14670,1,10, seconds remaining: -118587 -- Key: cqdTagPageBySlug:astro-2020, seconds remaining: -115382 -- Key: cqdPostsByTag:cqd-migrated-tag-22632,1,10, seconds remaining: -115318 -- Key: cqdTagPageBySlug:relapsing-remitting-multiple-sclerosis, seconds remaining: -114001 -- Key: cqdPostsByTag:cqd-migrated-tag-24805,1,10, seconds remaining: -113932 -- Key: cqdTagPageBySlug:scleritis, seconds remaining: -112172 -- Key: cqdPostsByTag:cqd-migrated-tag-21097,1,10, seconds remaining: -112099 -- Key: cqdTagPageBySlug:sideline-guidelines-app, seconds remaining: -109692 -- Key: cqdPostsByTag:cqd-migrated-tag-3734,1,10, seconds remaining: -109618 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:cancer-immunotherapy - retrieving from Sanity CCCache.dataFetchCount: 18646 Cache cleanup seconds remaining: 30000
Advertisement
Advertisement
Tag: cancer immunotherapy
Pembrolizumab does not improve outcomes, but immunotherapy may still offer benefit
Neoadjuvant immunotherapy improves outcomes
Real-world results reporting aims to make treatments safer and more effective
Blinatumomab plus chemotherapy improves overall survival and relapse-free survival over chemotherapy alone
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Patients receive specialized inpatient and outpatient care for cellular, gene and immune cell-engaging therapies
Enfortumab plus pembrolizumab reduced risk of death by 53% compared with platinum-based chemotherapy
Clinicians highlight the need to educate patients about warning signs
Combination therapy demonstrates effectiveness in first-line treatment setting
Research indicates strong rationale for expanding trial eligibility criteria
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Rendered: Mon Feb 09 2026 07:44:00 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.